Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Fungal Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05401071
What this trial is testing

Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

Who this might be right for
Tuberculosis, Pulmonary
Huashan Hospital 2,442
Not applicableLooking for participantsNCT03120481
What this trial is testing

Controls for Respiratory Diseases

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAsthmaIdiopathic Pulmonary Fibrosis+3 more
Seoul National University Hospital 1,572
Not applicableUnknownNCT03812666
What this trial is testing

Search for Biomarkers of Infection and Inflammation in Patients With Acute Stroke.

Who this might be right for
Stroke, AcutePneumonia, Bacterial
Jakob Ström 200
Testing effectiveness (Phase 2)Study completedNCT00021567
What this trial is testing

A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections

Who this might be right for
Mycobacterium Avium-Intracellulare Infection
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableNot Yet RecruitingNCT07067528
What this trial is testing

The Feasibility and Acceptability of a Post-tuberculosis Lung Disease Diagnostic Algorithm in Uganda.

Who this might be right for
Post Pulmonary TuberculosisPost-Tuberculous Bronchiectasis
Mbarara University of Science and Technology 80
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableUnknownNCT03910920
What this trial is testing

Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center.

Who this might be right for
Cystic FibrosisPseudomonas AeruginosaCross Infection
Queen Fabiola Children's University Hospital 15
Post-approval studies (Phase 4)Study completedNCT01193582
What this trial is testing

Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria

Who this might be right for
Pneumococcal Infections
Pfizer 505
Not applicableStudy completedNCT02787603
What this trial is testing

Procalcitonin in Early Antibiotic Interruption in Patient With Bacterial Pulmonary infeCtion and Acute Heart Failure

Who this might be right for
Respiratory Tract InfectionsPneumonia, BacterialHeart Failure
University of Sao Paulo General Hospital 46
Not applicableStudy completedNCT01301144
What this trial is testing

Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis

Who this might be right for
TuberculosisUrea Breath Test
National Institute of Allergy and Infectious Diseases (NIAID) 113
Testing effectiveness (Phase 2)Ended earlyNCT02940626
What this trial is testing

Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.

Who this might be right for
Pneumonia, Ventilator-associatedPneumonia, Staphylococcal
Arsanis, Inc. 155
Not applicableStudy completedNCT04645836
What this trial is testing

Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'.

Who this might be right for
Pulmonary TBTB
Xi'an Jiaotong University 450
Not applicableLooking for participantsNCT06950892
What this trial is testing

Remote Sputum Collection in Cystic Fibrosis

Who this might be right for
Cystic FibrosisInfections
University of Pennsylvania 150
Testing effectiveness (Phase 2)Study completedNCT00000811
What this trial is testing

Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children

Who this might be right for
Bacterial InfectionsPneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 690
Early research (Phase 1)Study completedNCT03182504
What this trial is testing

Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants

Who this might be right for
Gram-negative Bacterial Infections
Hoffmann-La Roche 21
Not applicableEnded earlyNCT03302949
What this trial is testing

Treating Tuberculosis Wasting With a High-protein Supplement

Who this might be right for
TuberculosisTuberculosis, PulmonaryUndernutrition+1 more
University of Aarhus 232
Not applicableStudy completedNCT04387799
What this trial is testing

Determinants of COVID-19 Pneumonia (MC-19)

Who this might be right for
Pneumonia, ViralPneumonia, BacterialCoronavirus Infection+1 more
Catholic University of the Sacred Heart 520
Testing effectiveness (Phase 2)Study completedNCT03702738
What this trial is testing

Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
The Aurum Institute NPC 110
Not applicableStudy completedNCT04970225
What this trial is testing

Cystic Fibrosis Blood Neutrophils

Who this might be right for
Cystic Fibrosis
Assistance Publique - Hôpitaux de Paris 47
Testing effectiveness (Phase 2)Ended earlyNCT02190604
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals 153
Next Page